Clinical trial
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- October 31, 2014
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal nocturnal hemoglobinuria, rheologic disease, sickle cell disease